Co-administration of cyclosporine A and imatinib among patients with Philadelphia chromosome-positive leukemias in the post-transplant setting

被引：0
作者：
Ahmet Emre Eskazan
机构：
[1] Istanbul University,Division of Hematology, Department of Internal Medicine, Cerrahpasa Faculty of Medicine
来源：
European Journal of Clinical Pharmacology | 2016年 / 72卷
关键词：
Imatinib; Tacrolimus; Chronic Myeloid Leukemia; Calcineurin Inhibitor; Lymphoid Leukemia;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1537 / 1538
页数：1
相关论文
共 45 条
  • [31] Long-term follow-up of imatinib plus combination chemotherapy in patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia
    Lim, Sung-Nam
    Joo, Young-Don
    Lee, Kyoo-Hyung
    Kim, Dae-Young
    Lee, Je-Hwan
    Lee, Jung-Hee
    Chi, Hyun-Sook
    Yun, Sung-Cheol
    Lee, Won Sik
    Lee, Sang Min
    Park, Seonyang
    Kim, Inho
    Sohn, Sang Kyun
    Moon, Joon Ho
    Ryoo, Hun-Mo
    Bae, Sung Hwa
    Hyun, Myung Soo
    Kim, Min Kyoung
    Kim, Hyeoung Joon
    Yang, Deok-Hwan
    Eom, Hyeon-Seok
    Lee, Gyeong-Won
    Jung, Chul Won
    Won, Jong-Ho
    Kim, Hawk
    Lee, Jae-Hoon
    Shin, Ho-Jin
    Jang, Dae-Young
    AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (11) : 1013 - 1020
  • [32] Efficacy and prognostic factors of imatinib plus CALLG2008 protocol in adult patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia
    Yinjun Lou
    Yafang Ma
    Chenyin Li
    Sansan Suo
    Hongyan Tong
    Wenbin Qian
    Wenyuan Mai
    Haitao Meng
    Wenjuan Yu
    Liping Mao
    Juyin Wei
    Weilei Xu
    Jie Jin
    Frontiers of Medicine, 2017, 11 : 229 - 238
  • [33] Dasatinib-related pleural effusion and lymphocytosis rates are different between adult and pediatric patients with Philadelphia chromosome-positive leukemias: are age and comorbidities only to blame?
    Kilicaslan, Necati Alp
    Borekci, Sermin
    Ozdemir, Gul Nihal
    Sayitoglu, Muge
    Eskazan, Ahmet Emre
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2022, 16 (08) : 849 - 852
  • [34] Prospective monitoring of BCR-ABL1 transcript levels in patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia undergoing imatinib-combined chemotherapy
    Yanada, Masamitsu
    Sugiura, Isamu
    Takeuchi, Jin
    Akiyama, Hideki
    Maruta, Atsuo
    Ueda, Yasunori
    Usui, Noriko
    Yagasaki, Fumiharu
    Yujiri, Toshiaki
    Takeuchi, Makoto
    Nishii, Kazuhiro
    Kimura, Yukihiko
    Miyawaki, Shuichi
    Narimatsu, Hiroto
    Miyazaki, Yasushi
    Ohtake, Shigeki
    Jinnai, Itsuro
    Matsuo, Keitaro
    Naoe, Tomoki
    Ohno, Ryuzo
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 143 (04) : 503 - 510
  • [35] Treatment of young patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia using increased dose of imatinib and deintensified chemotherapy before allogeneic stem cell transplantation
    Ribera, Josep-Maria
    Garcia, Olga
    Montesinos, Pau
    Brunet, Salut
    Abella, Eugenia
    Barrios, Manuel
    Gonzalez-Campos, Jose
    Bravo, Pilar
    Amigo, Maria-Luz
    Hernandez-Rivas, Jesus-Maria
    BRITISH JOURNAL OF HAEMATOLOGY, 2012, 159 (01) : 78 - 81
  • [36] Karyotype at diagnosis is the major prognostic factor predicting relapse-free survival for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with imatinib-combined chemotherapy
    Yanada, Masamitsu
    Takeuchi, Jin
    Sugiura, Isamu
    Akiyama, Hideki
    Usui, Noriko
    Yagasaki, Fumiharu
    Nishii, Kazuhiro
    Ueda, Yasunori
    Takeuchi, Makoto
    Miyawaki, Shuichi
    Maruta, Atsuo
    Narimatsu, Hiroto
    Miyazaki, Yasushi
    Ohtake, Shigeki
    Jinnai, Itsuro
    Matsuo, Keitaro
    Naoe, Tomoki
    Ohno, Ryuzo
    HAEMATOLOGICA, 2008, 93 (02) : 287 - 290
  • [37] Prediction of risk of disease recurrence by genome-wide cDNA microarray analysis in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with imatinib-combined chemotherapy
    Zembutsu, Hitoshi
    Yanada, Masamitsu
    Hishida, Asahi
    Katagiri, Toyomasa
    Tsuruo, Takashi
    Sugiura, Isamu
    Takeuchi, Jin
    Usui, Noriko
    Naoe, Tomoki
    Nakamura, Yusuke
    Ohno, Ryuzo
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2007, 31 (02) : 313 - 322
  • [38] Long-term response to imatinib is not affected by the initial dose in patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: final update from the Tyrosine Kinase Inhibitor Optimization and Selectivity (TOPS) study
    Baccarani, Michele
    Druker, Brian J.
    Branford, Susan
    Kim, Dong-Wook
    Pane, Fabrizio
    Mongay, Lidia
    Mone, Manisha
    Ortmann, Christine-Elke
    Kantarjian, Hagop M.
    Radich, Jerald P.
    Hughes, Timothy P.
    Cortes, Jorge E.
    Guilhot, Francois
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2014, 99 (05) : 616 - 624
  • [39] Long-term response to imatinib is not affected by the initial dose in patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: final update from the Tyrosine Kinase Inhibitor Optimization and Selectivity (TOPS) study
    Michele Baccarani
    Brian J. Druker
    Susan Branford
    Dong-Wook Kim
    Fabrizio Pane
    Lidia Mongay
    Manisha Mone
    Christine-Elke Ortmann
    Hagop M. Kantarjian
    Jerald P. Radich
    Timothy P. Hughes
    Jorge E. Cortes
    François Guilhot
    International Journal of Hematology, 2014, 99 : 616 - 624
  • [40] Results of triple therapy with interferon-alpha, cytarabine, and homoharringtonine, and the impact of adding imatinib to the treatment sequence in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in early chronic phase
    O'Brien, S
    Giles, F
    Talpaz, M
    Cortes, J
    Rios, MB
    Shan, JQ
    Thomas, D
    Andreeff, M
    Kornblau, S
    Fadedl, S
    Garcia-Manero, G
    White, K
    Mallard, S
    Freireich, E
    Kantarjian, HM
    CANCER, 2003, 98 (05) : 888 - 893
12345